{"ModuleTitle": "Company Description", "CompanyName": "Quidel Corporation", "Symbol": "QDEL", "Address": "9975 SUMMERS RIDGE ROAD, SAN DIEGO, California, 92121, United States of America", "Phone": "8585521100", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "All references to \"we,\" \"our,\" and \"us\" in this Annual Report refer to Quidel\r\nCorporation and its subsidiaries.\r\nOverview\r\nWe have a leadership position in the development, manufacturing and marketing of\r\nrapid diagnostic testing solutions. These diagnostic testing solutions are\r\nseparated into our four product categories: rapid immunoassay, cardiac\r\nimmunoassay, specialized diagnostic solutions and molecular diagnostic\r\nsolutions. We sell our products directly to end users and distributors, in each\r\ncase, for professional use in physician offices, hospitals, clinical\r\nlaboratories, reference laboratories, urgent care clinics, leading universities,\r\nretail clinics, pharmacies and wellness screening centers. We market our\r\nproducts through a network of distributors and through a direct sales force. We\r\noperate in one business segment that develops, manufactures and markets our four\r\nproduct categories.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f13%2f0000353569-20-000018.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Douglas C. Bryant", "title": "President, Chief Executive Officer & Director"}, {"name": "Karen S. Gibson", "title": "SVP-Information Systems & Business Transformation"}, {"name": "Randall J. Steward", "title": "Chief Financial Officer"}, {"name": "Ratan S. Borkar", "title": "Senior VP-International Commercial Operations"}, {"name": "Werner Kroll", "title": "Senior Vice President-Research & Development"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}